About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

LSD Therapy for Persons Suffering From Major Depression

NCT03866252·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital, Basel, Switzerland

With

Department of Psychiatry Basel (UPK Basel; Prof. Dr. med. Stefan Borgwardt)

Age

25–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Major Depressive Disorder according to Diagnostic and Statistical Manual of Mental Disorders (DSM-V)
\> 25 years
Sufficient understanding of the German language

You may not be if

\< 25 years
Concomitant diagnosis of past or present psychotic disorder
Concomitant diagnosis of past or present bipolar disorder
First degree relative with a psychotic disorder
Unable or unwilling to discontinue antidepressant medication
Pregnancy or breastfeeding
Known hypersensitivity to LSD
Somatic disorders including central nervous system (CNS) involvement
Known or suspected non-compliance, drug or alcohol abuse
Metal implants
Weight \< 42 kg
Suicide risk or very likely to require psychiatric hospitalisation

The record

StatusCompleted

PhasePhase 2

Taking part60

StartedNov 2019

UpdatedApr 23, 2025

Conditions

Major Depressive Disorder

Where1

Universitäre Psychiatrische Kliniken
Basel, Canton of Basel-City, Switzerland

Clareo Health | LSD Therapy for Persons Suffering From Major Depression